26 May 2013
Keywords: epilepsy, market, sees, strong, growth, remains, dynamic
Article | 29 July 1997
The epilepsy market remains a dynamic $2 billion global growth category,with the number of US prescriptions being written showing healthy
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
31 July 1997
24 May 2013
© 2013 thepharmaletter.com